Shadowfax Technologies Employee Stock Options
Shadowfax Technologies allotted 17,61,552 equity shares on exercise of ESOPs at Rs 10 per option. Money realised totals Rs 1.76 Crore.
- Value
- ₹1.76 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
66 announcements with these filters
Shadowfax Technologies allotted 17,61,552 equity shares on exercise of ESOPs at Rs 10 per option. Money realised totals Rs 1.76 Crore.
Shadowfax Technologies allotted 17,61,552 equity shares to employees exercising options under its SFX ESOP 2016 plan. The exercise price is Rs 10 per share.
Shadowfax hit record ₹1,538 Cr revenue and 5% EBITDA margin, signaling strong transition toward profitability.
Shadowfax submitted CARE Ratings' monitoring agency report on IPO proceeds for the quarter ended September 30, 2026. The report shows no deviation from the offer objects.
Q2 FY27 revenue ₹1,538 Cr (+56.6% YoY), PAT ₹68 Cr (4.4% margin), Adj. EBITDA ₹77 Cr (5.0% margin); speed-led share gains across Express, Hyperlocal and Prime D2C.
Shadowfax reported Q2 FY27 revenue of ₹1,538 Cr, up 56.6% YoY, with PAT at ₹68 Cr. Sixth consecutive 55%+ growth quarter, Adj. EBITDA margin at 5.0%.
Shadowfax Technologies Ltd reported revenue from operations of ₹1,538 Cr (+56.6% YoY) and net profit of ₹68 Cr (+423.1% YoY) for Q2 FY27.
Shadowfax Technologies will hold a board meeting on 29 October 2026 to approve September 2026 quarter results. An earnings call follows the same day at 5 p.m.
Shadowfax Technologies Limited is incorporating a wholly-owned subsidiary with a cash investment of ₹0.1 Crore.
Shadowfax Technologies Limited announced the exercise of 49,098 stock options, realizing Rs. 4.91 Lakhs from the employee stock option scheme.
Shadowfax Technologies Limited allotted equity shares under its Employee Stock Option Plan. This ESOP allotment resulted in a minor increase in the company's paid-up share capital.
Shadowfax Technologies approved the incorporation of a new wholly owned subsidiary in India. Additionally, the company allotted 49,098 equity shares following the exercise of ESOPs.
Shadowfax Technologies updated its Corporate Identification Number (CIN) from U72300KA2015PLC150324 to L72300KA2015PLC150324, following its recent listing on NSE and BSE exchanges.
NewQuest Asia Fund IV (Singapore) Pte. Ltd. sold 1,50,00,396 equity shares of Shadowfax Technologies Limited in the open market. This divestment reduced its stake from 9.26% to 6.69%.
Shadowfax Technologies Limited allotted equity shares under its Employee Stock Option Plan (ESOP). This issuance increases the company's paid-up share capital.
Shadowfax Technologies Limited allotted 55,110 equity shares to eligible employees upon exercise of stock options under the company's ESOP 2016 scheme.
Shadowfax Technologies Limited appointed M/s S.R. Batliboi & Associates LLP as its new Statutory Auditor following the conclusion of its 11th AGM.
Shadowfax filed proceedings of its 11th AGM held Sept 18, 2026. Agenda covered FY26 financials adoption, director re-appointment, auditor appointment, and executive remuneration increases.
Shadowfax Technologies Ltd exercised 1,57,314 stock options, realizing Rs. 15.73 Lakh. This ESOP exercise increases the company's equity capital.
Shadowfax Technologies allotted 1,57,314 equity shares to eligible employees upon the exercise of stock options under the SFX ESOP 2016 scheme.
Shadowfax Technologies launched its Channel Partner Program to expand Shadowfax 360 into an assisted distribution network. The company targets onboarding 1,000 partners over three years.
Shadowfax Technologies Limited has allotted 1,69,338 equity shares upon the exercise of stock options. The company realized Rs. 0.17 Crore from this issuance.
Shadowfax Technologies Limited allotted 1,69,338 equity shares to employees exercising stock options under the SFX ESOP 2016 plan.
Shadowfax Technologies Limited informed shareholders with unregistered emails about how to access the Annual Report and AGM Notice for FY 2025-26 via its website.
Shadowfax Technologies will hold its 11th Annual General Meeting on September 18, 2026, via video conferencing to consider financial reports and director/auditor appointments.
Shadowfax Technologies Limited allotted 1,241,478 equity shares under its ESOP 2016 plan. This increases the company's total paid-up share capital to 586,561,228 shares.
Shadowfax Technologies Limited allotted 12,41,478 equity shares to employees following the exercise of stock options. This allotment increases the company's paid-up capital to Rs. 586.56 Crore.
NewQuest Asia Fund IV Singapore sold 1,33,24,824 equity shares of Shadowfax Technologies via open market. This transaction reduced its stake from 11.53% to 9.26%.
Shadowfax Technologies Limited announced the grant of 3,333 stock options to eligible employees under its SFX ESOP 2016 scheme.
Mr. Nitesh Lohiya, Chief Product Officer of Shadowfax Technologies Limited, has resigned from his position, effective August 07, 2026.